Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

October 05, 2015 6:26 AM ET


Company Overview of Rottapharm S.p.A.

Company Overview

Rottapharm S.p.A. researches, develops, manufactures, markets, and distributes consumer healthcare products, reimbursed prescription products, and natural extracts in Italy and internationally. It offers various pharmaceutical products in the areas of cardiology, gastroenterology, gynecology, pediatrics, respiratory system, rheumatology, and urology; personal care products in the areas of gynecology, pediatrics, dermatology, sun protection, hair care, and others; and nutraceuticals in the areas of gynecology, cardiology, rheumatology, and dermatology. The company was founded in 1961 and is headquartered in Monza, Italy. As of October 10, 2014, Rottapharm S.p.A. operates as a subsidiary of Me...

Via Valosa di Sopra, 9

Monza, MI 20900


Founded in 1961

1,792 Employees


39 03 973901

Key Executives for Rottapharm S.p.A.

Chairman and Chief Executive Officer
Age: 54
Chief Operating Officer and Director
Head of International Marketing
Head of Corporate Communications
Head of Human Resources
Compensation as of Fiscal Year 2015.

Rottapharm S.p.A. Key Developments

Meda AB, Rottapharm S.p.A. - M&A Call

To discuss the acquisition of Rottapharm¦Madaus by Meda

Rottapharm SpA Announces Earnings Results for the First Quarter of 2014

Rottapharm SpA announced earnings results for the first quarter of 2014. For the quarter, the company booked a net profit of EUR 2.1 million, compared with a net loss of EUR 3.3 million for the same period last year. Consolidated revenues grew 15.4% annually to EUR 116.6 million, driven by higher sales in Italy which accounted for 29% of all. Adjusted earnings before interest, tax, depreciation and amortization soared 106% to EUR 18.5 million and adjusted earnings before interest and tax surged 218% to EUR 12.7 million.

Similar Private Companies By Industry

Company Name Region
Laboratori Baldacci Spa Europe
Istituto Gentili S.p.A. Europe
Sirton Pharmaceuticals SpA Europe
Bruno Farmaceutici S.p.A. Europe
SIFI S.p.A Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Rottapharm S.p.A., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at